BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
32%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $3 |
78%
upside
| 1 | +3.7% |
0
%
| 11 Dec ‘25 29 days ago |
|
|
|
Buy
Maintained
| $16 |
231%
upside
| 4 | +5.8% |
0
%
| 19 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $9 |
95%
upside
| 3 | +16% |
0
%
| 13 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $13 |
45%
downside
| 3 | +77% |
0
%
| 12 Nov ‘25 1 month ago |
|
|
|
Buy
Initiated
| $62 |
14%
downside
| 1 | +75% |
0
%
| 17 Sep ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $3 |
733%
upside
| 2 | -52% |
0
%
| 18 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $3 |
388%
upside
| 1 | -17% |
0
%
| 15 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $6 |
152%
upside
| 1 | +56% |
0
%
| 13 Aug ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $16 |
105%
upside
| 3 | +99% |
0
%
| 12 Aug ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $116 | – | 2 | +58% |
0
%
| 18 Jun ‘25 6 months ago |
|